acute%20coronary%20syndromes%20w_out%20persistent%20st-segment%20elevation
ACUTE CORONARY SYNDROMES W/OUT PERSISTENT ST-SEGMENT ELEVATION
Acute coronary syndromes refer to any constellation of clinical symptoms compatible with acute myocardial ischemia which may be life-threatening.
It encompasses unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).
Unstable angina is the ischemic discomfort that presents without persistent ST-segment elevation on ECG and without the presence of cardiac markers in the blood.
Non-ST-segment elevation myocardial infarction is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs.
The patient typically presents with ischemic-type chest pain that is severe and prolonged and may occur at rest or may be caused by less exertion than previous episodes.
Drug Information

Indication: HTN, vasospastic (Prinzmetal's or variant angina) or chronic stable angina.

Indication: 1st-line treatment of HTN & myocardial ischaemia. Monotherapy or in combination w/ other antianginal drugs...

Indication: 1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or ...

Indication: HTN. 1st-line treatment of myocardial ischemia in fixed obstruction (stable angina) &/or vasoconstriction/...

Indication: Prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower...

Dosage: HTN 50-100 mg daily as a single dose. Arrhythmia Oral maintenance: 50-100 mg/day as a single dose. Angina 50 m

Indication: HTN, Prinzmetal's angina, heart failure or ischaemic heart disease. Prophylaxis of chronic stable angina pecto...

Indication: 1st-line treatment for HTN as monotherapy or combination w/ other antihypertensive agents; myocardial ischemia...

Dosage: HTN, angina pectoris & cardiac arrhythmias 100-200 mg as a single or divided dose. Increased as necessary.

Indication: HTN, CHD (angina pectoris), stable chronic heart failure w/ reduced systolic left ventricular function in addi...

2  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 10 Sep 2019
Use of aspirin in the primary prevention of cardiovascular disease (CVD) in patients with no prior CVD history yields protection against the risks of acute myocardial infarction (AMI) and ischaemic stroke, but at the expense of an increase of similar magnitude in the incidence of major bleeding, according to the results of a recent meta-analysis presented at the European Society of Cardiology (ESC) Congress 2019 in Paris, France.
Dr Margaret Shi, 6 days ago

A comprehensive model of care delivered by nonphysician health workers (NPHWs), involving primary care physicians and families that was informed by local context, substantially improved blood pressure (BP) control and cardiovascular disease (CVD) risk, according to results of the HOPE 4 trial reported at the European Society of Cardiology (ESC) Congress 2019 and World Congress of Cardiology (WCC) 2019.